Patents by Inventor Jan Emmerich

Jan Emmerich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230210951
    Abstract: The present disclosures is related to IL2 muteins and their uses in the treatment of human disease.
    Type: Application
    Filed: January 14, 2021
    Publication date: July 6, 2023
    Inventors: Jan Emmerich, Steve Kauder, Scott Alan McCauley
  • Publication number: 20230031597
    Abstract: The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease.
    Type: Application
    Filed: June 6, 2022
    Publication date: February 2, 2023
    Inventors: Jan Emmerich, Steve Kauder, Scott Alan McCauley, Martin Oft
  • Patent number: 11491205
    Abstract: The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: November 8, 2022
    Assignee: Synthekine, Inc.
    Inventors: Jan Emmerich, Steve Kauder, Scott Alan McCauley, Martin Oft
  • Publication number: 20210275641
    Abstract: The present disclosures related to human interleukin-2 (hIL2) muteins, pharmaceutical formulations thereof, methods for preparing interleukin-2 muteins, recombinant vectors and cells comprising nucleic acids encoding IL2 muteins and methods for the treatment of human disease.
    Type: Application
    Filed: January 14, 2021
    Publication date: September 9, 2021
    Inventors: Jan Emmerich, Steve Kauder, Scott Alan McCauley, Martin Oft